Our esteemed board guides our research decisions and provides thoughtful insight into this disease. We are deeply grateful for their dedication, time, and work.

Susan A. Slaugenhaupt, Ph.D.
Harvard Medical Center
Massachusetts General Hospital

Florian Eichler, MD, Ph.D.
Harvard Medical Center
Massachusetts General Hospital

Ayelet Zerem, MD
Tel Aviv Sourasky Medical Center
Ichilov Hospital

Michael Friedman, Ph.D.
Adverum Biotechnologies
Clinical Development and Medical Affairs Leadership in Gene Therapy, Retinal Disease, Rare Disease, and Inflammatory Disease